File name .JPG
File alt. text
Image should be px wide x px tall.
Select Image
home - Liver - Liver Failure - Acute Drug Liver Injury Written by Dr Sebastian Zeki

Assesses the severity of liver dysfunction and its prognostic
significance following haemorrhage

Knows importance of correcting hypovolaemia preventing
complications of GI bleeding and deterioration of liver function and
stopping bleeding

Knows the potential use of blood & clotting factors the role of
antibiotics the use of vasoconstrictors therapeutic endoscopy the
indication for transjugular intra-hepatic portosystemic shunt (TIPS) or
surgical shunt surgery

Aware of the specific complications of bleeding in cirrhotic patients –
including hepatic encephalopathy need for airway protection
nutrition identification of alcohol withdrawal

Shows proficiency in endoscopy – including emergency endoscopic
techniques of variceal band ligation endoscopic sclerotherapy
injection of cyanoacrylate glues for gastric varices

Can place safely and manage a Sengstaken tube in refractory
variceal bleeding

Can prevent and treat complications including hepatorenal failure
ascites spontaneous bacterial peritonitis and hepatic encephalopathy

Appreciates criteria for referral to specialist centre when appropriate –
such as with bleeding gastric or ectopic varices or consideration of

Appreciates need to treat patients using a multi–disciplinary approach
Shows understanding of an empathic approach which may involve


Knows risks and prognosis of recurrent variceal bleeding in cirrhotic

Aware of role of secondary prophylaxis with either non–selective ?-
blockers endoscopic ligation or both

Can select suitable endoscopic therapy and perform the appropriate
procedure competently

Appreciates the potential role of other specialists e g interventional
radiologists and nurse specialists



Understands the mechanisms of biliary metabolism the various
abnormalities that lead to hyperbilirubinaemia and knows and
recognises the causes of the various forms of jaundice

Selects and interprets appropriate investigations and formulate
management plans

Approaches patients presenting with jaundice in a logical and
methodical manner


Can define the different types (I and II) of hepatorenal

Knows the differential diagnosis of different types of renal
failure/impairment in liver disease

Understands the major and minor criteria in diagnosis of HRS and be
able to differentiate between HRS and acute kidney injury

Appreciates the prognostic significance of renal impairment in
patients with chronic liver disease

Knows the options for management and treatment of HRS the role of
colloids and vasoconstrictors as well as renal supportive treatment by

Uses and interprets result of sometimes complex investigations

Can judge when to involve other specialists especially nephrologists
radiologists and intensivists



Understands the pathogenesis of hepatic encephalopathy (HE)
Knows the differential diagnosis of HE including the existence of risk
factors for its causation including metabolic disorders and intracranial
structural disorders (such as subdural haematomas)

Knows factors that may precipitate HE including bleeding electrolyte
disturbance drugs or other organ failure

Knows the various treatment options appropriate for grade of severity

Can grade the mental state (Glasgow coma score and West Haven

Shows ability to differentiate between acute and acute on chronic liver

Can identify the patient at risk of raised intracranial pressure and
cerebral oedema

Selects and use investigations appropriately and determine timing of
airway protection

Appreciates the role of other specialists and interacts in a
professional manner with intensivists neurologists
neurophysiologists radiologists and other specialists

Makes referral where appropriate to specialist centre for liver



Understands the causes of acute hepatitis including viral druginduced alcohol-induced and auto-immune liver disease

Knows the appropriate plan of investigation and management of
specific diseases including the role of serological investigations and
liver biopsy

Takes an accurate history from patients with acute liver disease and
performs detailed clinical examination

Utilises investigation in a structured manner
Considers all therapeutic modalities and preparedness to refer to
specialist centre where diagnosis remains in doubt or appropriate
management cannot be performed


Methods GMP
Recognises and knows how to diagnose acute and chronic drug
induced liver injury and dysfunction
SCE 1,2
Aware of methods of diagnosis, role of liver biopsy and therapy
including role of steroids in treatment in selected cases
SCE, CbD 1
Understands the role of both prescription and recreational drugs and
the aetiology of a wide variety of liver disease and dysfunction often
requiring prompt intervention or involvement of specialist services
SCE, CbD 1,2,3
Has awareness of the range of iatrogenic liver dysfunction SCE, CbD 1,2,3
Able to interact with specialist pharmacy services. Can use yellow
card reporting system of potential adverse effects of drugs.



Understands the causes and pathophysiology of acute liver failure
Can plan appropriate investigation evaluate prognosis and construct
a detailed management plan

Identifies those potentially suitable for emergency liver transplantation
Develops ability to make accurate evaluation of patients with liver
failure at the stage of initial presentation

Can deliver management plan appropriately evaluate changes in
patient’s condition and react accordingly

Utilises the range of medical interventions necessary to support
critically ill patients

Demonstrates ability to identify patients at risk of developing acute
liver failure and understand the criteria for referral to specialist centres

Works collaboratively with nurses and all ITU staff as well as
colleagues in other clinical disciplines to deliver the highest standard
of clinical care

Communicates effectively and relates with empathy to family and
close friends of patients

Acute Drug Liver Injury

Acute liver injury Most common-Usually paracetamol followed by antibiotics, especially augmentin (cholestasis in young, cholestatic/mixed type in older) Steatosis This is uncommon.Clinical presentation is as per Reye's syndrome or acute fatty liver of pregnancy.Jaundice is mild and ALT < in cytotoxic injury.This is associated with a high mortality.The histology is microvesicu-lar and predominantly triglyceride.Microvesicular histology is especially true of steatohepa-titis related to Reye's syndrome, high-dose intrave-nous tetracycline, and amiodarone.Other drugs associated with microvesicular steatosis include : camphor, ; cocaine; piroxicam; tolmetin; valproic acid, ;zidovudine (AZT), stavudine, and didanosine (ddI).Herbal remedies are being increasingly identified as causes of steatosis and other forms of injury. Mixed pattern injuryThis gives an increased ALT and ALP.This can occur with phenytoin.There is an increased risk of developing chronic liver disease compared with other forms of hepatotoxicity. This resembles extrahepatic obstructive jaundice.Causes include augmentin; chlorpromazine;nafcillin; trimethoprim-sulfamethoxazole; rifampin; erythromycin estolate; captopril; estradiol; amiodarone.Pruritus and jaundice.ALT is usually < 8x.Prognosis is better than hepato-cellular injury, although fatalities have been reported.Four types of cholestasis can be seen on liver histology. HepatitisThe picture is similar to that seen in viral hepatitis- get a transami-nitis.Cytotoxic hepatocellular injury (best predictor is bilirubin >3xULN) is associated with a mortality rate of up to 10 % overall and up to 80 % or higher if ALF. Zonal necrosis is charac-teristic of compounds with predictable, dose-dependent, intrinsic toxicity, such as carbon tetrachloride (zone 3), paracetamol (zone 3), yellow phosphorus (mid-zonal), or iron sulfate (zone 1).No inflammatory response. Nonzonal necrosis -Viral hepatitis-like pattern.Seen with com-pounds with unpre-dictable idiosyn-cratic injury (eg, phenytoin, methyl-dopa, isoniazid, and diclofenac). -Canalicular (bland or noninflamm-tory) Cholestasis + little hepatocel-lular inflamm-tion.(normal ALT, Increased ALP)Assoc: Anabolic steroids/ OCP.Inhibit BSEP therefore stop hepatocyte bile secretion. -Hepatocanalicular (cholangiolitic or inflammatory) -P ortal inflammation, prominent cholesta-sis, and only slight hepatocellular injury in zones of cholesta-sis.ALT < x8; ALP 3-10x ULNCauses eg: captopril, chlorpromazine, dicloxacillin, erythro-mycin estolate, naproxen, sulfonylu-reas, and terbenifine. -Ducto-penic -Sclerosing cholangitis Cholestatic liver injury Written by Dr Sebastian Zeki

Related Stories

Role of AMP deaminase in diabetic cardiomyopathy

A novel prognostic model to predict mortality in patients with acute-on-chronic liver failure in intensive care unit

Anlotinib plus Sintilimab achieved in an antitumor effect of complete remission in a patient with advanced hepatocellular carcinoma: a case report

Liver Transplant for Hepatocellular Carcinoma in Post-Milan Criteria Era: A Long-Term Single-Center Experience

Therapeutic Plasma Exchange in Children With Acute and Acuteon-Chronic Liver Failure: A Single-Center Experience